BOA
CORZ icon

Birnam Oak Advisors’s Core Scientific CORZ Stock Holding History

Birnam Oak Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-646,323
Closed -$11.6M – 35
2025
Q3 		$11.6M Buy
+646,323
New +$9.48M 2.66% 14

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Birnam Oak Advisors's CORZ Position: Q4 2025 in Review

Birnam Oak Advisors sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 646,323 shares — an estimated $11.6M sold.

Birnam Oak Advisors first reported a position in CORZ in Q3 2025 and held it in 1 quarter. The position peaked at $11.6M in Q3 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • Birnam Oak Advisors reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
  • Birnam Oak Advisors sold 646,323 Core Scientific shares in Q4 2025, an estimated $11.6M.
  • Birnam Oak Advisors first reported a position in Core Scientific in Q3 2025 and held it in 1 quarter.
  • Birnam Oak Advisors's Core Scientific position peaked at $11.6M in Q3 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on Birnam Oak Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.